GlassScriptPhysician profile
Alan M Taylor
NPI 1649272923
$4,175.96
in general payments reported to CMS, 2019-2025
36 companies · $541 in 2025
The $541 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,005 · 2020: $363 · 2021: $602 · 2022: $799 · 2023: $761 · 2024: $104 · 2025: $541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,406.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $566.29 | 2021-2025 | Verquvo |
| Novartis Pharmaceuticals Corporation | $390.86 | 2019-2025 | |
| Tactile Systems Technology INC | $352.67 | 2022-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Pfizer INC. | $318.63 | 2019-2023 | |
| Abbott Laboratories | $315.89 | 2019-2024 | Ensite, Diamondback Peripheral |
| Amgen INC. | $314.72 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $313.46 | 2019-2024 | Camzyos, Eliquis |
| Esperion Therapeutics, INC. | $220.84 | 2021-2023 | Nexletol |
| Janssen Pharmaceuticals, INC | $154.24 | 2019-2023 | Xarelto |
| Akcea Therapeutics, INC. | $153.47 | 2019 | |
| Boston Scientific Corporation | $133.80 | 2021-2025 | Watchman, Bodyguardian, Varithena Administration Pack |
| Astrazeneca Pharmaceuticals LP | $106.01 | 2020-2022 | |
| Vital Connect, INC | $91.78 | 2025 | Vitalpatch Rtm |
| Kiniksa Pharmaceuticals, LTD. | $88.85 | 2021-2023 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $75.10 | 2019-2021 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $61.89 | 2021 | |
| Biotronik INC. | $56.04 | 2019-2022 | |
| Amarin Pharma, INC. | $49.12 | 2019-2020 | |
| Edwards Lifesciences Corporation | $39.75 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $37.31 | 2023 | Inpefa |
| Kowa Pharmaceuticals America, INC. | $36.29 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.99 | 2019-2021 | |
| Inspire Medical Systems, INC. | $33.31 | 2023-2025 | Inspire |
| Astellas Pharma US INC | $30.02 | 2019 | |
| Avinger INC. | $24.12 | 2020 | |
| Irhythm Technologies, INC. | $23.60 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $22.79 | 2019 | |
| Atricure, INC. | $22.62 | 2022 | |
| Impulse Dynamics (USA) INC. | $20.23 | 2023 | Optimizer |
| Glaxosmithkline, LLC. | $18.48 | 2025 | Shingrix, Arexvy |
| Scpharmaceuticals INC. | $15.52 | 2023 | |
| Angiodynamics, INC. | $12.80 | 2022 | |
| Cook Medical LLC | $12.33 | 2019 | |
| Chiesi USA, INC. | $12.02 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.43 | 2025 | Lifevest |
| Acist Medical Systems, INC. | $5.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.